Fatty fish: Data about the relation between fatty fish consumption and total cancer was provided by one cohort (Virtanen JK [14]). No significant
association was found at any level of consumption.
Lean fish: No data was found.
Conclusion: Little data was found. No evidence was found for an association between fatty fish intake and total cancer.
| Author | Cohort name | Subjects | Years of follow-up | Cases | End point | Consumption of | Relative Risk (RR) | Adjustments |
| 14) Virtanen JK (2008) | The Health Professionals Follow-up Study | 40,230 men aged 40-75 and free of major chronic disease. (USA) | 18 (1986-2004) | 4,690? | Primary cancer incidence (excluding nonmelanoma skin cancer and low-grade organ-confined prostate cancer) | Dark meat fish (such as mackerel, salmon, sardines, bluefish, and swordfish) |
RR = 1.02 (0.88-1.18; P = 0.96) for the highest vs lowest quartile of consumption. Amount specific data (servings): < 1/mo: RR = 1. 1-3/mo: RR = 0.96 (0.90-1.03). 1/wk: RR = 0.98 (0.90-1.07). ≥ 2/wk: RR = 1.02 (0.88-1.18). | Age, BMI, smoking, physical activity, history of diabetes, hypertension or hypercholesterolemia, first-degree family history of MI before age 60, first degree family history of colon cancer, aspirin use, multivitamin use, glycemic load, and intakes of protein, fiber, trans fat, saturated fat, n-6 fatty acids, alpha-linolenic acid, red meat, total calories, and alcohol. |